Concepedia

Yasir S. Raouf

YS

Statistics

Publications

11

Citations

301

H-Index

11

Active since

2019

Affiliations

University of Toronto(Current)

United Arab Emirates University

University of Hassan II Casablanca

McMaster University

Yasir S. Raouf is an author at University of Toronto specializing in pharmacology, cancer pharmacology, and drug discovery.

ORCID

Publications per year

2019–2025

11

Publications

11

Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia

Krimo Toutah, Nabanita Nawar, Sanna Timonen et al. · Journal of Medicinal Chemistry · 2021 · 46 citations · Full text

, , +16

PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia

Justyna M. Gawel, Andrew E. Shouksmith, Yasir S. Raouf et al. · European Journal of Medicinal Chemistry · 2020 · 41 citations · Full text

, , +8

Characterization of Conformationally Constrained Benzanilide Scaffolds for Potent and Selective HDAC8 Targeting

Muhammad Murtaza Hassan, Johan Israelian, Nabanita Nawar et al. · Journal of Medicinal Chemistry · 2020 · 39 citations · Full text

, , +13

Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer

Andrew E. Shouksmith, Fenil Shah, Michelle Grimard et al. · Journal of Medicinal Chemistry · 2019 · 37 citations · Full text

, , +10

Discovery of HDAC6-Selective Inhibitor NN-390 with <i>in Vitro</i> Efficacy in Group 3 Medulloblastoma

Nabanita Nawar, Shazreh Bukhari, Ashley Adile et al. · Journal of Medicinal Chemistry · 2022 · 31 citations · Full text

, , +15

1–5 of 11